ALGN
Price
$196.82
Change
-$0.16 (-0.08%)
Updated
Jul 3 closing price
Capitalization
24.63B
25 days until earnings call
VREX
Price
$8.80
Change
+$0.08 (+0.92%)
Updated
Jul 3 closing price
Capitalization
732.76M
30 days until earnings call
Interact to see
Advertisement

ALGN vs VREX

Header iconALGN vs VREX Comparison
Open Charts ALGN vs VREXBanner chart's image
Align Technology
Price$196.82
Change-$0.16 (-0.08%)
Volume$712.8K
Capitalization24.63B
Varex Imaging
Price$8.80
Change+$0.08 (+0.92%)
Volume$148.91K
Capitalization732.76M
ALGN vs VREX Comparison Chart in %
Loading...
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VREX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGN vs. VREX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a Hold and VREX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (ALGN: $196.82 vs. VREX: $8.80)
Brand notoriety: ALGN: Notable vs. VREX: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ALGN: 77% vs. VREX: 34%
Market capitalization -- ALGN: $24.63B vs. VREX: $732.76M
ALGN [@Medical Specialties] is valued at $24.63B. VREX’s [@Medical Specialties] market capitalization is $732.76M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGN’s FA Score shows that 0 FA rating(s) are green whileVREX’s FA Score has 0 green FA rating(s).

  • ALGN’s FA Score: 0 green, 5 red.
  • VREX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALGN and VREX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGN’s TA Score shows that 5 TA indicator(s) are bullish while VREX’s TA Score has 6 bullish TA indicator(s).

  • ALGN’s TA Score: 5 bullish, 4 bearish.
  • VREX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VREX is a better buy in the short-term than ALGN.

Price Growth

ALGN (@Medical Specialties) experienced а +4.84% price change this week, while VREX (@Medical Specialties) price change was +3.04% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.93%. For the same industry, the average monthly price growth was +1.81%, and the average quarterly price growth was -0.17%.

Reported Earning Dates

ALGN is expected to report earnings on Oct 29, 2025.

VREX is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Medical Specialties (+1.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALGN($24.6B) has a higher market cap than VREX($733M). ALGN has higher P/E ratio than VREX: ALGN (55.01) vs VREX (18.22). ALGN YTD gains are higher at: -5.606 vs. VREX (-39.685). ALGN has higher annual earnings (EBITDA): 799M vs. VREX (85.6M). ALGN has more cash in the bank: 973M vs. VREX (141M). ALGN has less debt than VREX: ALGN (127M) vs VREX (470M). ALGN has higher revenues than VREX: ALGN (3.86B) vs VREX (878M).
ALGNVREXALGN / VREX
Capitalization24.6B733M3,356%
EBITDA799M85.6M933%
Gain YTD-5.606-39.68514%
P/E Ratio55.0118.22302%
Revenue3.86B878M440%
Total Cash973M141M690%
Total Debt127M470M27%
FUNDAMENTALS RATINGS
ALGN vs VREX: Fundamental Ratings
ALGN
VREX
OUTLOOK RATING
1..100
3650
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6592
PRICE GROWTH RATING
1..100
5062
P/E GROWTH RATING
1..100
7047
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALGN's Valuation (76) in the Medical Specialties industry is in the same range as VREX (85). This means that ALGN’s stock grew similarly to VREX’s over the last 12 months.

ALGN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as VREX (100). This means that ALGN’s stock grew similarly to VREX’s over the last 12 months.

ALGN's SMR Rating (65) in the Medical Specialties industry is in the same range as VREX (92). This means that ALGN’s stock grew similarly to VREX’s over the last 12 months.

ALGN's Price Growth Rating (50) in the Medical Specialties industry is in the same range as VREX (62). This means that ALGN’s stock grew similarly to VREX’s over the last 12 months.

VREX's P/E Growth Rating (47) in the Medical Specialties industry is in the same range as ALGN (70). This means that VREX’s stock grew similarly to ALGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALGNVREX
RSI
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
72%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
74%
Momentum
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
64%
MACD
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
70%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 3 days ago
63%
Declines
ODDS (%)
Bearish Trend 23 days ago
70%
Bearish Trend 18 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VREX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SIL49.090.82
+1.70%
Global X Silver Miners ETF
UPW81.101.19
+1.49%
ProShares Ultra Utilities
DBJP76.720.89
+1.18%
Xtrackers MSCI Japan Hedged Equity ETF
EWO29.27-0.02
-0.07%
iShares MSCI Austria ETF
RFIX46.56-0.87
-1.83%
Simplify Downside Interest Rate Hedge Strategy ETF